Thymic lymphomas in mice with a truncating mutation in Brca2.
Friedman LS., Thistlethwaite FC., Patel KJ., Yu VP., Lee H., Venkitaraman AR., Abel KJ., Carlton MB., Hunter SM., Colledge WH., Evans MJ., Ponder BA.
Inherited mutations in the BRCA2 gene predispose women to breast and ovarian cancer. We created a mutation in the mouse Brca2 gene that terminates translation in exon 11 at 45% of the normal transcript length. Ninety % of Brca2(tm1Cam) homozygous mutant mice die prenatally or perinatally. The location of the Brca2(tm1Cam) mutation differs from those reported previously, and this phenotype suggests a correlation with genotype analogous to that previously reported in humans. Although heterozygote mice have remained free of tumors for 10 months, Brca2(tm1Cam) homozygous mutants that survived to adulthood died with thymic lymphomas between 12 and 14 weeks of age.